Skip to content

Minimally Invasive Holmium:YAG Laser Blepharoplasty

Minimally Invasive Holmium:YAG Laser Blepharoplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00842764
Enrollment
7
Registered
2009-02-12
Start date
2009-01-31
Completion date
2014-09-30
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Eyelid Entropion

Keywords

eyelid fat pads

Brief summary

The purpose of this research study is to is to evaluate the safety and effectiveness of the FDA approved Holmium:YAG laser for reducing lower eyelid bags.

Detailed description

The researchers are interested in learning if the more precise Holmium:YAG laser can effectively tighten the orbital septum, a barrier of the orbit which holds fat in the bony orbit, while resulting in less unintentional surrounding damage and side effects.

Interventions

PROCEDUREHolmium: YAG laser

Minimally Invasive Holmium:YAG laser Blepharoplasty

Sponsors

Beckman Laser Institute University of California Irvine
CollaboratorOTHER
University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* male/female 30 years and older * have pronounced lower eyelid fat pads.

Exclusion criteria

* based on medical problems. * Previous surgery or trauma to lower eyelid or orbit. * pregnant or lactating.

Design outcomes

Primary

MeasureTime frameDescription
Change in Lower Eyelid Bags.2 monthsPreoperative and postoperative (postoperative visits were at day 1, 1 week, 1 month, and 2 months) .photographs were evaluated by 6 surgeons on a 5-point Likert scale which 1 indicates worsening, 2 means unchanged, 3 is mild improvement, 4 is moderate improvement, and 5 indicates complete correction.

Countries

United States

Participant flow

Participants by arm

ArmCount
Holmium:YAG Laser
Minimally Invasive Holmium:YAG laser Blepharoplasty
7
Total7

Baseline characteristics

CharacteristicHolmium:YAG Laser
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
7 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
7 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 7
other
Total, other adverse events
0 / 7
serious
Total, serious adverse events
0 / 7

Outcome results

Primary

Change in Lower Eyelid Bags.

Preoperative and postoperative (postoperative visits were at day 1, 1 week, 1 month, and 2 months) .photographs were evaluated by 6 surgeons on a 5-point Likert scale which 1 indicates worsening, 2 means unchanged, 3 is mild improvement, 4 is moderate improvement, and 5 indicates complete correction.

Time frame: 2 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Holmium:YAG LaserChange in Lower Eyelid Bags.Preoperative5 Participants
Holmium:YAG LaserChange in Lower Eyelid Bags.Postoperative5 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026